Skip to main content
OpenTrials
Completed

NCT Number: NCT04240938

Adult Dacryocystocele Among Patients With Epiphora

Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were done for them after their evaluation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine

Minya, Minya Governorate, 61111, Egypt

About this study

Evaluation for lacrimal passage in the included patients using syringing, probing and dye disappearance test. Dacryocystorhinostomy were done for all patients and followed up for at least 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lacrimal sac mucocele
  • Acquired type

Exclusion criteria

  • No previous lacrimal sac surgery
  • Suspected lacrimal sac malignancy

Treatment and study plan

Dacryocystorhinostomy

Procedure

Anastomosis between lacrimal sac and nasal cavity

Primary outcomes

  1. Patency of the lacrimal passage

    Time frame: 2 weeks

    Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test

  2. Disappearance of lacrimal sac swelling

    Time frame: 1 month

    No evident swelling in the medial side of the eye

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Adult Encysted Dacryocystocele: Prevalence Among Patients With Epiphora and Its Management

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jan 27, 2020
Registry last updated
Jan 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.